SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending amid investor unease over a reported multi-billion dollar financing backstop for OpenAI, which has sparked intense debate regarding "circular financing" and credit risk in the AI infrastructure sector. While some market participants express concern over the scale of AI capital expenditures and recent sector-wide weakness, others in the community view the dip as a tactical opportunity to accumulate shares ahead of upcoming earnings.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing significant volatility as investors weigh concerns about potential long-term competition from Chinese memory manufacturers against strong institutional demand for AI-driven storage. While some in the community see the recent sharp pullback as a panic-induced buying opportunity given the company's robust backlog and fundamentals, others are rotating out of semiconductor names due to fears that the sector's valuation cycle has hit a peak.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is currently at the center of a high-stakes discussion as investors weigh a massive revenue beat and significant contract backlog against concerns over dilution and GAAP losses. While the community remains deeply polarized between long-term bulls highlighting robust AI infrastructure demand and skeptics pointing to sequential margin pressure, the stock is seeing intense volatility as participants react to the company's aggressive growth strategy versus broader macroeconomic headwinds.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to a significant sell-off following the release of an FDA advisory committee briefing document that questioned the statistical methodology and efficacy of its Duchenne muscular dystrophy treatment. While the community is actively debating the severity of these regulatory concerns and the validity of the FDA's analysiswhich Capricor claims relied on an obsolete internal draftinvestors are closely watching the upcoming advisory committee meeting for a potential binary outcome that could redefine the company's future.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is currently trending as investors weigh significant analyst upgrades and positive long-term outlooks against broad volatility within the semiconductor sector. The community remains divided between long-term bulls who point to robust AI infrastructure demand and data center expansion, and traders reacting to short-term price fluctuations ahead of the company's upcoming earnings report.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Semiconductor investors are currently navigating high volatility driven by a mix of strong corporate earnings, such as those from Intel, and ongoing geopolitical tensions in the Middle East that continue to weigh on the sector. Community sentiment remains deeply divided, with traders aggressively debating whether the recent price swings represent a bottoming opportunity or a warning sign of further downside in an AI-focused market.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is facing significant volatility as investors weigh the company's strong revenue growth against concerns over high capital spending and intensifying competition in the semiconductor sector. The community remains deeply divided, with many debating whether the recent price decline represents a temporary pullback in a long-term AI infrastructure play or a deeper structural issue for the chipmaker.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is experiencing intense volatility as investors weigh concerns over AI infrastructure spending, semiconductor sector weakness, and broader economic uncertainty. Community sentiment is deeply divided, with traders actively debating whether the current sell-off represents a structural collapse or a strategic buying opportunity ahead of key central bank policy decisions and major tech earnings.

Amkor Technology, Inc. engages in the provision of outsourced semiconductor packaging and test services. Its services include design, package characterization, test, and wafer bumping services. The company was founded in 1968 and is headquartered in Tempe, AZ.

AMKOR Technology Inc.

Amkor Technology is trending as investors digest a secondary share offering by the Kim family, which increased the float without dilution, while the community continues to debate the long-term potential of the company's advanced packaging capacity and its strategic integration into the AI and semiconductor supply chain.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as investors debate the impact of the upcoming post-TDAPA reimbursement landscape and speculate on potential legislative catalysts like the Kidney Care Access Protection Act. While community discourse remains polarized between long-term optimism over DefenCath's clinical adoption and skepticism regarding institutional management and near-term revenue volatility, active discussions center on whether current valuation levels represent an attractive entry point or a period of prolonged stagnation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exclusive: Imunon Says Lead Drug Continues To Show Promise in Advanced Ovarian Cancer Patients

Imunon reports early Phase 2 data showing lower residual disease and higher ctDNA clearance with IMNN-001 in ovarian cancer.read more...

Imunon (IMNN) Q1 2026 Earnings Transcript

@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...

Exploring Imunon's Earnings Expectations

Imunon Doses First Patient With Experimental Cancer Drug In Late-Stage Trial: Retail Thinks Company Is Undervalued

Equity

The trial is evaluating IMNN-001 in the treatment of women with newly diagnosed advanced ovarian cancer. 


Imunon Jumps 96% On Phase 2 Immune Biomarker Data Reveal Ahead of ESMO Congress; Retail Expects ‘Major’ Partnership News Soon

The data highlights promising results for IMNN-001, an IL-12 gene therapy for advanced ovarian cancer, boosting investor optimism ahead of its Phase 3 trial.

Retail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’

Shares jumped 15.5% after hours, as retail traders pointed to “much better funding options” hinted at during the firm’s recent earnings call.

Imunon, Inc. is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm is also engaged in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Imunon Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

The Fed's July 28-29 meeting has markets debating a hold versus a hike, not a cut, with CME FedWatch pricing roughly a 65% chance of no change and rising odds of a September rate increase amid inflation running well above the 2% target. What do you expect the Fed to decide? Drop a comment with when you expect the first cut/hike to be.

What do you expect the Fed to decide at its FOMC meeting?  
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$1.53
Prev Close	$1.51
Open	$1.52
Dividend Yield	0.00%
50-Day Moving Average	$1.97
Beta	0.36
Avg. Volume	73,782.15
PE Ratio	-0.30

52-Week High	$8.19
52-Week Low	$1.48
Market Capitalization	$6.35M
EPS (Annual)	-$6.83
Price to Book	1.79
Revenue Per Employee	$0.00

Feed

News

Sentiment

Fundamentals

Info

IMNNImunon Inc

Latest IMNN News